FIBROGEN INC
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
KYNB$3.90+4.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
(In thousands)
| Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net loss | $(284,232) | $(293,654) | $(290,023) |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustments | (3,712) | 75 | 1,235 |
| Available-for-sale investments: | |||
| Unrealized gain (loss) on investments, net of tax effect | 2,557 | (1,632) | (899) |
| Other comprehensive gain (loss), net of taxes | (1,155) | (1,557) | 336 |
| Comprehensive loss | (285,387) | (295,211) | (289,687) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.